Headquartered in Reykjavik, Iceland, deCODE is a global leader in analyzing and understanding the human genome. Using unique expertise and population resources, deCODE has discovered key genetic risk factors for dozens of common diseases ranging from cardiovascular disease to cancer. deCODE genetics ehf, also known as Islensk erfdagreining, is now a subsidiary of Amgen. The firm develops and offers diagnostic tests for variants in genes. The company was founded in 1996 and is based in Reykjavik, Iceland. deCODE genetics ehf is a former subsidiary of deCODE genetics Inc.